Functional roles of multiple feedback loops in extracellular signal-regulated kinase and Wnt signaling pathways that regulate epithelial-mesenchymal transition.
暂无分享,去创建一个
Kwang-Hyun Cho | Sung-Young Shin | Walter Kolch | Oliver Rath | Kwang-Hyun Cho | O. Rath | W. Kolch | Sung-Young Shin | S. Choo | A. Zebisch | Sang-Mok Choo | Armin Zebisch
[1] Sven Diederichs,et al. The hallmarks of cancer , 2012, RNA biology.
[2] Kwang-Hyun Cho,et al. Positive- and negative-feedback regulations coordinate the dynamic behavior of the Ras-Raf-MEK-ERK signal transduction pathway , 2009, Journal of Cell Science.
[3] W. Kolch,et al. Snail is a repressor of RKIP transcription in metastatic prostate cancer cells , 2008, Oncogene.
[4] M. Rosner,et al. Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor , 2008, Cell Research.
[5] W. Kolch,et al. Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability , 2008, Journal of Clinical Pathology.
[6] A. Adjei,et al. Advances in Targeting the Ras/Raf/MEK/Erk Mitogen-Activated Protein Kinase Cascade with MEK Inhibitors for Cancer Therapy , 2008, Clinical Cancer Research.
[7] M. Taketo,et al. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene , 2007, Journal of Cell Science.
[8] C. Heldin,et al. Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression , 2007, Cancer science.
[9] M. Mimeault,et al. Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] D. Kim,et al. A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK Pathways , 2007, Oncogene.
[11] B. Rubino,et al. The role of epithelial-mesenchymal transition in cancer pathology. , 2007, Pathology.
[12] O. Rath,et al. MAP kinase signalling pathways in cancer , 2007, Oncogene.
[13] Y. Surh,et al. Axin Inhibits Extracellular Signal-regulated Kinase Pathway by Ras Degradation via β-Catenin* , 2007, Journal of Biological Chemistry.
[14] J. Jass,et al. Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. , 2007, American journal of clinical pathology.
[15] W. Kolch,et al. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Raghu Kalluri,et al. The epithelial–mesenchymal transition: new insights in signaling, development, and disease , 2006, The Journal of cell biology.
[17] Y. Surh,et al. APC inhibits ERK pathway activation and cellular proliferation induced by RAS , 2006, Journal of Cell Science.
[18] Y. Zhou,et al. Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase , 2006, Oncogene.
[19] M. Almeida,et al. Wnt Proteins Prevent Apoptosis of Both Uncommitted Osteoblast Progenitors and Differentiated Osteoblasts by β-Catenin-dependent and -independent Signaling Cascades Involving Src/ERK and Phosphatidylinositol 3-Kinase/AKT* , 2005, Journal of Biological Chemistry.
[20] Karin Oien,et al. Reduction of Raf-1 Kinase Inhibitor Protein Expression Correlates with Breast Cancer Metastasis , 2005, Clinical Cancer Research.
[21] Jun Qin,et al. Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin , 2005 .
[22] E. Keller,et al. The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein , 2005, Journal of cellular biochemistry.
[23] M. Hung,et al. Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition , 2004, Nature Cell Biology.
[24] A. Asthagiri,et al. Epidermal Growth Factor-mediated T-cell Factor/Lymphoid Enhancer Factor Transcriptional Activity Is Essential but Not Sufficient for Cell Cycle Progression in Nontransformed Mammary Epithelial Cells* , 2004, Journal of Biological Chemistry.
[25] K. Yeung,et al. Raf kinase inhibitor protein: a prostate cancer metastasis suppressor gene. , 2004, Cancer letters.
[26] Reinhart Heinrich,et al. The Roles of APC and Axin Derived from Experimental and Theoretical Analysis of the Wnt Pathway , 2003, PLoS biology.
[27] M. Rubin,et al. Effects of Raf Kinase Inhibitor Protein Expression on Suppression of Prostate Cancer Metastasis , 2003 .
[28] K. Wolff,et al. Fibroblast Growth Factor-2 Induces Lef/Tcf-dependent Transcription in Human Endothelial Cells* , 2002, The Journal of Biological Chemistry.
[29] Kathleen R. Cho,et al. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. , 2002, The Journal of biological chemistry.
[30] Kathleen R. Cho,et al. Activation of AXIN2 Expression by β-Catenin-T Cell Factor , 2002, The Journal of Biological Chemistry.
[31] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[32] Choun-Ki Joo,et al. Wnt/β-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway , 2002, Molecular and Cellular Biology.
[33] R. Knuechel,et al. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[34] F. Bertrand,et al. Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation , 2001, Oncogene.
[35] I. Beavon. The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. , 2000, European journal of cancer.
[36] W. Kolch,et al. Mechanism of Suppression of the Raf/MEK/Extracellular Signal-Regulated Kinase Pathway by the Raf Kinase Inhibitor Protein , 2000, Molecular and Cellular Biology.
[37] W. Kolch,et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP , 1999, Nature.
[38] J. Pessin,et al. SOS Phosphorylation and Disassociation of the Grb2-SOS Complex by the ERK and JNK Signaling Pathways (*) , 1996, The Journal of Biological Chemistry.
[39] S. Paul,et al. Wnt signaling and cancer development: therapeutic implication. , 2008, Neoplasma.
[40] Jun Qin,et al. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. , 2005, Molecular cell.
[41] Hans Clevers,et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. , 2002, Cell.
[42] F. Bertrand,et al. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. , 2001, Oncogene.
[43] Ronald J. Tocci,et al. Digital Systems: Principles and Applications , 1977 .